<DOC>
	<DOCNO>NCT01816074</DOCNO>
	<brief_summary>We hypothesize successfully treat maternal Attention Deficit Hyperactivity Disorder ( ADHD ) beneficial effect extend child . We believe multi-component intervention combine maternal stimulant medication , Lisdexamfetamine ( LDX ) , Behavioral Parent Training ( BPT ) improve parenting , maternal , child outcome . In term improve parenting , hypothesize mother may respond well LDX BPT alone therefore may require multi-modal treatment , whereas others may benefit multi-modal treatment</brief_summary>
	<brief_title>Sequencing Treatments Mothers With ADHD Their At - Risk Children</brief_title>
	<detailed_description>The overarch goal study construct evaluate adaptive intervention ( i.e. , individualize treatment protocol adjust base child-mother dyad 's initial response treatment ) improve trajectory ADHD outcomes at-risk child . Our primary outcome measure child whether child ADHD symptoms Conners Parent Teacher Rating Scales decrease completion study . Our secondary outcome measure whether need medication child course study . The primary outcome mother Conners Adult ADHD Rating Scale ( CAARS ) Attention Scale Clinical Global Impression-Severity scale ( CGI-S ) .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Mothers Sign inform consent Be 2150 year old ( inclusive ) screen visit Englishspeaking At screen ( washout , require ) meet full Diagnostic Statistical Manual ( DSMIV ) criterion ADHD , subtype Have current CGISADHD rating &gt; 4 &lt; 8 Have finding physical exam ( PE ) , laboratory study , vital sign , electrocardiogram ( ECG ) judge normal age contraindication methylphenidate ( MPH ) treatment Have pulse blood pressure ( BP ) within 95 % age gender mean Commit entire visit schedule study Be able complete study assessment Women childbearing potential ( surgically sterile postmenopausal ) must agree use medicallyaccepted contraception method consistently Mothers comorbid mood/anxiety disorder effectively treat Selective Serotonin Reuptake Inhibitors ( SSRIs ) eligible participation , provide medication change within 30 day , well tolerate , current mood symptom severe associate active suicidal ideation . Also , prescribe physician must approve participation study . Mothers History allergic reaction severe negative response study medication History alcohol/substance abuse past 3 month positive urinary toxic screen initial evaluation explain timelimited medical circumstance History current bipolar illness , schizophrenia , psychosis , significant suicidal risk History chronic acute medical disorder stimulant therapy would contraindicate ( e.g. , glaucoma , hypertension ) Child Sign assent old 6 Be age 48 symptom ADHD ( Conners Hyperactivity Index &gt; 60 ) , prior treatment effective dos stimulant , define one week treatment adequate dos .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Mothers</keyword>
	<keyword>ADHD</keyword>
	<keyword>Treatment</keyword>
	<keyword>Child</keyword>
</DOC>